Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review
Cureus · 24.06.2026
DOI: 10.7759/cureus.111445 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 24.06.2026. Verfasst von Raafat Mady und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Kettering General Hospital, Kettering, GBR. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Kettering General Hospital, Kettering, GBR.
- Department of Breast Surgery, Blackrock Clinic, Dublin, IRL.
- Department of Medical Oncology, Kettering General Hospital, Kettering, GBR.
- Radiology Department, Breast Cancer Center, American Hospital, Dubai, ARE.
Zitieren
APA
Mady, R., Tafazal, H., Soliman, H., Ramadan, A., & Hajaj, M. (2026). Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.111445
Vancouver
Mady R, Tafazal H, Soliman H, Ramadan A, Hajaj M. Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review. Cureus. 2026. doi:10.7759/cureus.111445
BibTeX
@article{Mady2026,
author = {Mady, Raafat and Tafazal, Habib and Soliman, Haitham and Ramadan, Ayman and Hajaj, Mohamed},
title = {Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.111445}
}
EUVIMED